Abstract
The N-terminal hexapeptide of glucagon and the corresponding carboxamide analog, were prepared by solid-phase synthesis and tested for biological activity in the hepatic adenylate cyclase system. Both peptides were found to be inactive, even at concentrations of 10 mM. The differences observed in the activity of our compounds compared to previous reports, is ascribed to the presence of a contaminant found in earlier preparations which activates adenylate cyclase.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1307-1314 |
| Number of pages | 8 |
| Journal | Life Sciences |
| Volume | 33 |
| Issue number | 13 |
| DOIs | |
| State | Published - Sep 26 1983 |
| Externally published | Yes |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
- General Pharmacology, Toxicology and Pharmaceutics
Fingerprint
Dive into the research topics of 'Re-evaluation of glucagon1-6: The N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase system'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS